The Technical Analyst
Select Language :
Atreca Inc [BCEL]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Atreca Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Atreca Inc is listed at the  Exchange

6.67% $0.0800

America/New_York / 28 mar 2024 @ 15:53


FUNDAMENTALS
MarketCap: 3.17 mill
EPS: -2.50
P/E: -0.0300
Earnings Date: Mar 28, 2024
SharesOutstanding: 39.62 mill
Avg Daily Volume: 8.56 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Strong Sell
DE: Neutral
P/E: Neutral
Price To Book: Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0300 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.01x
Company: PE -0.0300 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.0480 - 0.112

( +/- 40.00%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-10-19 Baker Bros. Advisors Lp Sell 251 902 Class A common stock
2023-10-19 Baker Bros. Advisors Lp Sell 22 837 Class A common stock
2023-09-17 Ruiz Roger Richard Sell 0 Class A Common Stock
2023-09-17 Ruiz Roger Richard Sell 27 000 Employee stock option (right to buy)
2023-09-17 Ruiz Roger Richard Sell 25 000 Employee stock option (right to buy)
INSIDER POWER
31.01
Last 95 transactions
Buy: 4 503 145 | Sell: 1 985 486

Forecast: 16:00 - $0.0800

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.0800
Forecast 2: 16:00 - $0.0800
Forecast 3: 16:00 - $0.0800
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.0800 (6.67% )
Volume 0.0812 mill
Avg. Vol. 8.56 mill
% of Avg. Vol 0.948 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Atreca Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Atreca Inc

RSI

Intraday RSI14 chart for Atreca Inc

Last 10 Buy & Sell Signals For BCEL

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:29buy$0.268N/AActive
Profile picture for
            Atreca Inc

BCEL

Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology; licensing agreement with the Bill & Melinda Gates Medical Research Institute for the development and commercialization of MAM01/ATRC-501 for the prevention of malaria. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California.

Last 10 Buy Signals

Date Signal @
BFICUSDMar 29 - 07:079.89
RETH2USDMar 29 - 06:593 540.59
PUNDIXUSDMar 29 - 06:580.696
STRKUSDMar 29 - 06:58$14.20
ATMUSDMar 29 - 06:53$3.38
USDDUSDMar 29 - 06:480.997
ETHWUSDMar 29 - 06:484.35
GRTUSDMar 29 - 06:45$0.398
KCSUSDMar 29 - 06:44$11.84
GTUSDMar 29 - 06:43$9.65

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.